SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-357401
Filing Date
2017-11-30
Accepted
2017-11-30 16:49:32
Documents
4
Period of Report
2017-11-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d500988d8k.htm 8-K 14560
2 EX-99.1 d500988dex991.htm EX-99.1 10675
3 GRAPHIC g500988g1201022134681.jpg GRAPHIC 631
4 GRAPHIC g500988g1201022134977.jpg GRAPHIC 3881
  Complete submission text file 0001193125-17-357401.txt   33131
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 171231711
SIC: 2834 Pharmaceutical Preparations